OpenAI’s 37-year-old CEO bet $180 million on a little-known biotech startup that’s trying to help people live 10 years longer

From Jeff Bezos to Jack Dorsey, billionaires are using their wealth to fight aging. According to a report by MIT Technology Review, OpenAI CEO Sam Altman is among the group. Altman has quietly funded a longevity startup with $180 million, MIT Technology Review said. Anti-aging and longevity investments are becoming popular among the rich.

Read More from the Global Wellness News ™

Save Your Cart
Share Your Cart